Camlin Fine Sciences cuts standalone losses, but revenue also shrank
Standalone net loss narrowed sharply in FY26, but the improvement came from lower revenue, not growth. Consolidated profit was a one-off from a European liquidation.
— 3 earlier stories on Camlin Fine Sciences Ltd. →What's new
- Standalone net loss narrowed to ₹3,296.62 lakh in FY26 from ₹7,631.05 lakh in the prior year.
- Standalone revenue declined to ₹83,791.82 lakh from ₹88,649.13 lakh.
- Consolidated net profit of ₹2,762.72 lakh was driven by a gain from CPS Europe liquidation.
Why this matters
The loss reduction is welcome, but it was achieved on a smaller revenue base, suggesting cost cuts rather than a sales rebound. The consolidated profit is non-recurring, masking the fact that the core standalone operations are still deep in the red.
What we're watching
- Whether standalone losses continue to narrow in FY27 on an organically growing top line.
- The rationale behind the simultaneous CFO appointment and re-designation.
- How consolidated results look once the CPS Europe liquidation gain is no longer a factor.
The full read
Camlin Fine Sciences' FY26 results show a company cutting its standalone losses but not yet growing. The standalone net loss fell to ₹3,296.62 lakh from ₹7,631.05 lakh the year before, a material improvement. But standalone revenue also shrank to ₹83,791.82 lakh from ₹88,649.13 lakh, meaning the better bottom line came from a smaller top line. At the consolidated level, the company posted a profit of ₹2,762.72 lakh. That number, however, is a one-off, driven by a gain from the liquidation of CPS Europe. Strip out that discontinued-operation event and the core business remains loss-making. The board also approved a new CFO and re-designated the existing one, adding a layer of management change to an operational story that is still about managing decline, not reversing it.
Questions answered
- How did Camlin's core standalone business perform in FY26?
- The standalone net loss narrowed to ₹3,296.62 lakh from ₹7,631.05 lakh in FY25. However, standalone revenue also fell to ₹83,791.82 lakh from ₹88,649.13 lakh, indicating the loss improvement came from tighter spending.
- Why was consolidated net profit positive?
- Consolidated net profit attributable to owners was ₹2,762.72 lakh, driven almost entirely by a one-time gain from the liquidation of CPS Europe, a discontinued operation. The core business remained unprofitable.
- What management changes were announced alongside the results?
- The board approved the appointment of a new CFO and simultaneously re-designated the existing CFO to a different role. This signals a restructuring at the top of the finance function.
- Is the narrowing standalone loss a sign of recovery?
- The loss narrowed by about 57%, which is a significant reduction. But it occurred alongside a revenue decline, suggesting the improvement is from cost management rather than renewed growth in the core business.
Camlin Fine Sciences Ltd.
Latest quarter · Mar 2026
Strength & growth
Story so far
All notes on CAMLINFINE →- 26 May 2026 · 4:43 PM IST Camlin Fine Sciences cuts standalone losses, but revenue also shrank
- 3d ago Camlin Fine's top R&D scientist resigns citing personal commitments
- 45d ago Camlin Fine Sciences cuts vanillin price guidance as costs surge
- 45d ago Camlin profit on Italian sale masks a still-lossmaking core